Jaguar Health, Inc. cash flow to debt ratio of 13.30% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Jaguar Health, Inc.'s free cash flow has increased -119.49% from $-29.61M last year to $5.77M, signaling increasing performance

Jaguar Health, Inc.'s debt to equity ratio is -3.09, signaling that the company spent its equity and risk bankruptcy.

Jaguar Health, Inc.'s debt to equity ratio is -3.09, signaling that the company spent its equity and risk bankruptcy.

Jaguar Health, Inc. has negative EBITDA, making leverage ratio unreliable

Jaguar Health, Inc.'s interest coverage ratio is -36.18, which means that the company struggles to meet interest obligations, signaling financial risk.

Jaguar Health, Inc.'s profit margin has increased (-64.96%) in the last year from -329.30% to -115.39%, signaling increasing performance

Jaguar Health, Inc.'s short-term liabilities of $40.65M exceed its short-term assets of $20.34M, signaling financial risk

Jaguar Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Jaguar Health, Inc.'s return on equity of 764.53%, is higher than 15.00%, indicating good performance

Jaguar Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Jaguar Health, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Jaguar Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Jaguar Health, Inc. has a free cash flow yield of 3.99K%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Jaguar Health, Inc.'s yearly earnings has decreased 39.18% since last year from $-38.49M to $-53.58M, signaling decreasing performance

Jaguar Health, Inc.'s yearly revenue has decreased -1.52% since last year from $11.69M to $11.51M, signaling decreasing performance

ROIC -89.32% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Jaguar Health, Inc.'s 3-year revenue CAGR of -1.26% is negative, indicating declining revenue over the past 3 years

Jaguar Health, Inc. had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance

Jaguar Health, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Jaguar Health, Inc. has insufficient data to evaluate this check.

Jaguar Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Jaguar Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Jaguar Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Jaguar Health, Inc. is overvalued relative to its fair value price of -8.07K based on Earnings Fair Value model

Jaguar Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Jaguar Health, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Jaguar Health, Inc. has a price-to-sales ratio of 0.04x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue